Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Privitera

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
The Indian Journal of Medical Research|August 12, 2021
Effects of infections on the pathogenesis of cancerRocco Luca Emanuele Liardo, Antonio Maria Borzì, Corrado Spatola, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Drug Development in Inflammatory Bowel Diseases: What Is Next?Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Journal of Clinical Medicine|July 12, 2025
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative ColitisLaura Parisio, Giuseppe Cuccia, Anna Giudice, et al.
Expert Opinion on Biological Therapy|August 12, 2024
How comparative studies can inform treatment decisions for Crohn's diseaseGiuseppe Privitera, Cristina Bezzio, Arianna Dal Buono, et al.
Frontiers in Immunology|July 30, 2025
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammationGiulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, et al.
Future Oncology (London, England)|December 4, 2019
Adenoid cystic carcinoma of trachea: long-term disease control after endoscopic surgery and radiotherapyCorrado Spatola, Alessandra Tocco, Dario Marletta, et al.
Annals of the New York Academy of Sciences|April 4, 2007
Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiationIvan M Petrović, Lela B Korićanac, Danijela V Todorović, et al.
Journal of Clinical Medicine|April 14, 2026
New Technologies for IBD EndoscopyCristina Bezzio, Valeria Farinola, Giuseppe Privitera, et al.
Crohn'S & Colitis 360|November 13, 2025
Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical TrialRoberto Gabbiadini, Demis Pitoni, Peter Bertoli, et al.
International Journal of Molecular Sciences|June 13, 2025
TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic PotentialEnrico Tettoni, Roberto Gabbiadini, Arianna Dal Buono, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
The Indian Journal of Medical Research|August 12, 2021
Effects of infections on the pathogenesis of cancerRocco Luca Emanuele Liardo, Antonio Maria Borzì, Corrado Spatola, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Drug Development in Inflammatory Bowel Diseases: What Is Next?Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Journal of Clinical Medicine|July 12, 2025
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative ColitisLaura Parisio, Giuseppe Cuccia, Anna Giudice, et al.
Expert Opinion on Biological Therapy|August 12, 2024
How comparative studies can inform treatment decisions for Crohn's diseaseGiuseppe Privitera, Cristina Bezzio, Arianna Dal Buono, et al.
Frontiers in Immunology|July 30, 2025
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammationGiulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, et al.
Future Oncology (London, England)|December 4, 2019
Adenoid cystic carcinoma of trachea: long-term disease control after endoscopic surgery and radiotherapyCorrado Spatola, Alessandra Tocco, Dario Marletta, et al.
Annals of the New York Academy of Sciences|April 4, 2007
Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiationIvan M Petrović, Lela B Korićanac, Danijela V Todorović, et al.
Journal of Clinical Medicine|April 14, 2026
New Technologies for IBD EndoscopyCristina Bezzio, Valeria Farinola, Giuseppe Privitera, et al.
Crohn'S & Colitis 360|November 13, 2025
Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical TrialRoberto Gabbiadini, Demis Pitoni, Peter Bertoli, et al.
International Journal of Molecular Sciences|June 13, 2025
TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic PotentialEnrico Tettoni, Roberto Gabbiadini, Arianna Dal Buono, et al.
Pageof 10